仙樂健康(300791.SZ):延長控股股東、實控人、董事和高管限售股鎖定期
格隆匯3月25日丨仙樂健康(300791.SZ)公佈,公司控股股東廣東光輝投資有限公司(“廣東光輝”)、實際控制人林培青和陳瓊、董事和高級管理人員楊睿、董事姚壯民發行前所持公司股份的鎖定期延長6個月,具體情況如下:

值得注意的是,林培青、陳瓊和姚壯民的間接持股是通過廣東光輝持有。楊睿的1.20%間接持股是通過汕頭市正諾投資合夥企業(有限合夥)持有,1.44%的間接持股是通過廣東光輝持有。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.